Found: 9
Select item for more details and to access through your institution.
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
- Published in:
- Diabetologia, 2023, v. 66, n. 1, p. 132, doi. 10.1007/s00125-022-05812-4
- By:
- Publication type:
- Article
An Insulin-Chromogranin A Hybrid Peptide Activates DR11-Restricted T Cells in Human Type 1 Diabetes.
- Published in:
- Diabetes, 2024, v. 73, n. 5, p. 743, doi. 10.2337/db23-0622
- By:
- Publication type:
- Article
CD4<sup>+</sup> T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.
- Published in:
- Diabetes, 2024, v. 73, n. 5, p. 728, doi. 10.2337/db23-0588
- By:
- Publication type:
- Article
Recognition of mRNA Splice Variant and Secretory Granule Epitopes by CD4<sup>+</sup> T Cells in Type 1 Diabetes.
- Published in:
- Diabetes, 2023, v. 72, n. 1, p. 85, doi. 10.2337/db22-0191
- By:
- Publication type:
- Article
Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Citrullination of glucokinase is linked to autoimmune diabetes.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29512-0
- By:
- Publication type:
- Article
Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes.
- Published in:
- Biomedicines, 2021, v. 9, n. 2, p. 202, doi. 10.3390/biomedicines9020202
- By:
- Publication type:
- Article
Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.668680
- By:
- Publication type:
- Article